Item 2. Properties
Item 2.
Properties.
 
  The
Company’s executive office and principal manufacturing
facility for its Benchtop Laboratory Equipment operations comprises
approximately 19,000 square feet. This facility is located in
Bohemia, New York and is held under a lease which expires in
February 2025. The Company’s Catalyst Research Instruments
operations are conducted from an approximately 9,000 square foot
facility in Pittsburgh, Pennsylvania under a lease which expires in
November 2020. The Bioprocessing Systems operations are conducted
from an approximately a 1,400 square foot laboratory facility in
Pittsburgh Pennsylvania under a lease which expires in May 2021.
The Company has a 1,200 square foot facility in Orangeburg, New
York from where it conducts its sales and marketing functions,
primarily for the Torbal Products Division of the Benchtop
Laboratory Equipment operations expiring in October 2022. See Note
11 to the consolidated Financial Statements in Item 8. The leased
facilities are suitable and adequate for each of the
Company’s operations. In the opinion of management, all
properties are adequately covered by insurance.
    
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.